Latest filing published 12 Apr 2023 for Immunovia, €1,651.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Philipp Mathieu: trading record in brief
This profile gathers the share dealings of Philipp Mathieu in Immunovia. Between 20 May 2022 and 6 April 2023, the trades on record add up to 3 filings.
The open-market record is one-sided, with 2 purchases worth €29k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2023 alone, the filings show 1 purchase and no sales.
The record was last updated on 12 April 2023 with an open-market purchase (€1,651) in Immunovia. The median gap between a trade and its publication by Finansinspektionen is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Philipp Mathieu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,808 shares@ SEK 6.703.8% of flowBTA (betald tecknad aktie)ISIN SE0019913559FI:csv-4b27808ea1804190bf77Canonical exit: 5 Jul 2023 (T+90)
- 150,000 shares@ SEK 1.9863.2% of flowTeckningsoptionISIN SE0006091997FI:csv-4e49d6e34876dfd58de7Canonical exit: 13 Feb 2023 (T+90)
- 100,000 shares@ SEK 1.50100.0% of flowWarrantFI:csv-15bcec2be9ae94dfe32d
3 of 3 declarations